Does Rallies show Form 4 insider transactions for ASBP?

Yes. Rallies tracks ASBP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ASBP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.

ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - Insider Trades

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of May 21, 2026, ASBP trades at $5.95 with a market cap of $8.09M and a P/E ratio of 0.00. ASBP moved +2.06% today. Year to date, ASBP is -95.82%; over the trailing twelve months it is -97.91%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ASBP stock inside the company?

Recent ASBP insider activity includes Fell Donald G. bought 10.50K, Fell Donald G. sold 10.50K, Fell Donald G. bought 9.50K, Fell Donald G. sold 9.50K, and LUTE CHRISTOPHER H bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ASBP Key Metrics

Key financial metrics for ASBP
Metric	Value
Price	$5.95
Market Cap	$8.09M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.16%
52-Week High	$11,832.00
52-Week Low	$3.31
Volume	1.39K
Avg Volume	0
Revenue (TTM)	$6.20K
Net Income	$-24.48M
Gross Margin	0.00%

Recent ASBP Insider Trades

Fell Donald G. bought 10.50K (~$4.09K) on Jun 5, 2025.
Fell Donald G. sold 10.50K (~$4.09K) on Jun 5, 2025.
Fell Donald G. bought 9.50K (~$3.71K) on Jun 4, 2025.
Fell Donald G. sold 9.50K (~$3.71K) on Jun 4, 2025.
LUTE CHRISTOPHER H bought 1.00K (~$20.75K) on Sep 30, 2005.

Latest ASBP News

Aspire Biopharma Approves One-for-Thirty Reverse Split to Meet Nasdaq Bid Rule — May 7, 2026
Aspire Biopharma Raises $21M, Secures $22.5M Facility for $30M Dura Control Systems Acquisition — Apr 20, 2026
Aspire Biopharma to Acquire Automotive Supplier with $200M Revenue for $30M Cash — Apr 16, 2026
Aspire Biopharma Partners with Interwest to Scale Buzz Bomb in Utah, Idaho and Montana — Apr 15, 2026
Aspire Biopharma Secures TruLife Deal to Launch BUZZ BOMB in Mass and Specialty Retail — Mar 19, 2026

ASBP Analyst Consensus

ASBP analyst coverage data. Average price target: $0.00.

Common questions about ASBP

Who is trading ASBP stock inside the company?: Recent ASBP insider activity includes Fell Donald G. bought 10.50K, Fell Donald G. sold 10.50K, Fell Donald G. bought 9.50K, Fell Donald G. sold 9.50K, and LUTE CHRISTOPHER H bought 1.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ASBP?: Yes. Rallies tracks ASBP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ASBP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.